financetom
Business
financetom
/
Business
/
Saint-Gobain agrees to buy FOSROC for around $1 billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Saint-Gobain agrees to buy FOSROC for around $1 billion
Jun 27, 2024 12:04 AM

(Reuters) -France's Saint-Gobain has entered into an agreement to buy Dubai-based construction chemicals company FOSROC for around 960 million euros ($1.03 billion) to drive its international expansion, it said on Thursday.

The transaction, which will be fully financed with cash, is expected to close by the first half of 2025, the French construction materials group said.

Saint-Gobain has been on the hunt for acquisitions outside of Europe as it seeks to grow its worldwide presence in construction chemicals.

Since 2021, the Paris-based multinational has bought 35 companies, including Chryso and GCP that operate in the sector.

The deal to buy FOSROC, based in the United Arab Emirates, will allow the group to expand in high-growth markets such as India and the Middle East, CEO Benoit Bazin said in a statement.

Saint-Gobain expects to realise synergies of $54 million in the third year after the deal is completed.

($1 = 0.9351 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rocket Pharmaceuticals Files Mixed-Shelf Offering
Rocket Pharmaceuticals Files Mixed-Shelf Offering
Aug 16, 2024
05:00 PM EDT, 08/16/2024 (MT Newswires) -- Rocket Pharmaceuticals ( RCKT ) on Friday filed a registration statement with the US Securities and Exchange Commission for the potential sale of securities from time to time in one or more offerings. The statement covers common and preferred shares, debt securities, warrants, and units, the filing showed. The company plans to use...
Q2 Holdings Insider Sold Shares Worth $788,040, According to a Recent SEC Filing
Q2 Holdings Insider Sold Shares Worth $788,040, According to a Recent SEC Filing
Aug 16, 2024
04:57 PM EDT, 08/16/2024 (MT Newswires) -- Jonathan Price, Executive Vice President, Strategy & Emerging Businesses, on August 16, 2024, sold 11,000 shares in Q2 Holdings ( QTWO ) for $788,040. Following the Form 4 filing with the SEC, Price has control over a total of 215,079 shares of the company, with 215,079 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1410384/000141038424000164/xslF345X03/wk-form4_1723841630.xml ...
Goosehead Insurance Insider Sold Shares Worth $851,691, According to a Recent SEC Filing
Goosehead Insurance Insider Sold Shares Worth $851,691, According to a Recent SEC Filing
Aug 16, 2024
04:58 PM EDT, 08/16/2024 (MT Newswires) -- Patrick Ryan Langston, 10% Owner, on August 14, 2024, sold 10,000 shares in Goosehead Insurance ( GSHD ) for $851,691. Following the Form 4 filing with the SEC, Langston has control over a total of 5,000 shares of the company, with 5,000 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1726978/000172697824000075/xslF345X03/wk-form4_1723841576.xml ...
ARCA biopharma to Distribute Special Dividend Conditional on Shareholder Approval of Oruka Therapeutics Merger
ARCA biopharma to Distribute Special Dividend Conditional on Shareholder Approval of Oruka Therapeutics Merger
Aug 16, 2024
04:59 PM EDT, 08/16/2024 (MT Newswires) -- ARCA biopharma (ABIO) said late Friday that it will distribute a special dividend estimated to be $1.59 per share, subject to approval of the proposed merger with Oruka Therapeutics by ARCA shareholders. The exact amount of the dividend will be based on the merger agreement and ARCA's estimate of how much its net...
Copyright 2023-2026 - www.financetom.com All Rights Reserved